Is delivery critical or just get it close enough to tissue in ROI?

Are we aiming to modify specific cells/layers? And what happens to adjacent tissue that is 'accidentally' modified?

Do you have any literature recommendations on the state of the art in Gene Therapy 'delivery' mechanisms/apparatus?